Alessandra Narcisi

9PUBLICATIONS
100CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyPainEpidemiological methodsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 03, 2026
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.

|Apr 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).

Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya

|Mar 23, 2026
Lebrikizumab After Multiple Prior Advanced Therapies in Moderate-To-Severe Atopic Dermatitis: A Real-World Case Series.

Giovanni Paolino, Matteo Riccardo Di Nicola, Luciano Ibba

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

|Oct 29, 2025
Real-Life Effectiveness and Safety of Bimekizumab in Plaque Psoriasis Involving Difficult-to-Treat Areas: A 52-Week, Retrospective Real-World, Single-Center Study.

Matteo Bianco, Francesco D'Oria, Gioele Ghezzi

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

Pageof 2

Frequent Collaborators

7 joint publications

Antonio Costanzo

6 joint publications

Luigi Gargiulo

4 joint publications

Silvia Mariel Ferrucci

4 joint publications

Mario Valenti